A prospective cohort study of pregnancy outcomes following antepartum infection with SARS-CoV-2

James D. Doss, Emily Diveley, Fan Zhang, Amy Scheffer, Ruizhi Huang, Daniel Jackson, Nandini Raghuraman, Ebony Carter, Indira Mysorekar, Jeannie C. Kelly

Research output: Contribution to journalArticlepeer-review

Abstract

Objectives: Our study aimed to explore the impact of COVID-19 infection on pregnancy outcomes, accounting for the progression of variants, vaccines, and treatment modalities. Study Design: We performed a prospective longitudinal cohort study at two urban tertiary centers enrolling patients with a confirmed intrauterine singleton pregnancy from December 23, 2020 to July 18, 2022. Patients were evaluated for SARS-CoV-2 infection at enrollment and every trimester using serum antibody testing. The primary outcome was preterm birth. Symptom and treatment data were collected from pregnant patients with COVID-19 infections. Variant strain infection status was determined from local wastewater analysis. Results: 448 patients were enrolled, and 390 patients were retained through delivery with 159 unexposed and 231 exposed patients, of whom 56 patients (26.0 %) crossed over after enrollment to the exposed cohorts during pregnancy. There was no difference in rates of preterm birth between exposed and unexposed cohorts (14.6 % vs 11.3 %), in deliveries < 34 weeks (1.5 % vs 2.7 %), PPROM, (0.4 % vs 1.3 %), or gestational age at delivery (38.1 vs 38.2). Exposed patients were significantly more likely to be diagnosed with a hypertensive disorder (aOR 2.3, 95 % CI 1.2–4.1), specifically gestational hypertension (aOR 2.8, 95 % CI 1.3––6.0), but not preeclampsia/eclampsia. There were no differences in individual or composite neonatal outcomes. Conclusions: Our study contributed to the understanding of the effects of SARS-CoV-2 infection on pregnancy outcomes, with increased risk of hypertensive disorders of pregnancy but overall, no differences in adverse neonatal outcomes. Regular antenatal PCR and antibody screening allowed for higher detection and inclusion of patients with asymptomatic SARS-CoV-2 infection and effects on maternal and neonatal outcomes.

Original languageEnglish
Article number101152
JournalPregnancy Hypertension
Volume37
DOIs
StatePublished - Sep 2024

Keywords

  • Antepartum infectious disease
  • COVID-19
  • Hypertensive disorders of pregnancy
  • Preterm delivery
  • SARS-CoV-2
  • SARS-CoV-2 vaccination in pregnancy

Fingerprint

Dive into the research topics of 'A prospective cohort study of pregnancy outcomes following antepartum infection with SARS-CoV-2'. Together they form a unique fingerprint.

Cite this